Virus News and Research

Latest Virus News and Research

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in federal court today claiming Abbott's blockbuster drug, Humira, caused a fungal infection resulting in the near-death of a Tennessee man.

14 Jun 2011

Universal influenza vaccination may reduce health care costs in the U.S.

Implementing a recommendation that all Americans be vaccinated against influenza may dramatically reduce health care costs and the number of people infected with seasonal influenza in the United States.

14 Jun 2011

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

Response Biomedical Corporation announced that it has received a notification from the U.S. Food and Drug Administration (FDA) that its NTproBNP Assay did not meet the criteria to obtain a waiver under the Clinical Laboratory Improvement Amendments of 1988.

14 Jun 2011

Scientists identify six influenza A viruses similar to 2009 pandemic strain

Scientists using new mathematical and computational techniques have identified six influenza A viruses that have particularly close genetic relationships to the H1N1 "swine" flu virus that swept through the United States beginning in the spring of 2009. That virus eventually killed almost 18,000 people worldwide.

14 Jun 2011

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.

14 Jun 2011

Cinryze data on hereditary angioedema presented at EAACI 2011

ViroPharma Incorporated today announced that data relating to Cinryze from nine accepted abstracts were presented as poster presentations at the 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI), June 11 through 15, in Istanbul, Turkey.

14 Jun 2011

Viewpoints: Private vs. public Medicare; N.J. Medicaid tough choices; IPAB's cost controls

Every once in a while a politician comes up with an idea that's so bad, so wrongheaded, that you're almost grateful. For really bad ideas can help illustrate the extent to which policy discourse has gone off the rails. And so it was with Senator Joseph Lieberman's proposal, released last week, to raise the age for Medicare eligibility from 65 to 67.

14 Jun 2011

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.

13 Jun 2011

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Vertex Pharmaceuticals Incorporated and Alios BioPharma, Inc. today announced an exclusive worldwide licensing agreement that will add two distinct nucleotide analogues to Vertex's hepatitis C portfolio.

13 Jun 2011

S. African government program reduced MTCT HIV transmission rate to 3.5%, study shows

The South African government's program to prevent mother-to-child transmission (PMTCT) of HIV has reduced the rate of virus transmission to about 3.5 percent, "potentially sparing some 67,000 babies from HIV infection," according to research presented on Wednesday by the Medical Research Council at the 5th South African AIDS Conference in Durban, Health-e/allAfrica.com reports.

13 Jun 2011

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Biota Holdings Limited advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

10 Jun 2011

Swine flu may have been more widespread in Scotland than previously believed, study says

Up to two million people in Scotland may have been infected with swine flu during the outbreak of winter 2009-2010, making the flu much more widespread than previously thought, according to a study published by researchers from the University of Edinburgh in PLoS One, BBC News reports.

10 Jun 2011

Quest Diagnostics receives MDEA gold award for Simplexa/3M technology

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that its Simplexa molecular diagnostic test on the 3M Integrated Cycler won a gold award in the in vitro diagnostics category at the 2011 MDEA awards ceremony yesterday in New York City.

From Quest Diagnostics 10 Jun 2011

Global initiative to prevent HIV in babies

World leaders met to decide on the launch of a global plan with the goal of ensuring that every baby is born HIV-free by 2015 and that their mothers with the HIV virus live to raise them.

9 Jun 2011

Ilex, Cerus partner to distribute INTERCEPT Blood System in Israel and South Africa

Cerus Corporation today announced today that it has entered into agreements with Ilex Biotech Limited to distribute Cerus' INTERCEPT Blood System for platelets and plasma in South Africa and Israel.

9 Jun 2011

Adults with herpes zoster may face higher risk of multiple sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack.

9 Jun 2011

Adjuvant combination generates memory CD8 T cells which could kill infected cells

Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.

9 Jun 2011

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.

9 Jun 2011

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

Scientists at Rockefeller University and The Scripps Research Institute have developed the first genetically humanized mouse model for hepatitis C, an achievement that will enable researchers to test molecules that block entry of the hepatitis C virus into cells as well as potential vaccine candidates. The finding is reported in the June 9 issue of the journal Nature.

9 Jun 2011

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease continues to be the most common indication for liver transplantation (LT) in the United States accounting for nearly 50% of all liver transplants. Recurrence is universal in patients viremic at the time of transplantation with histological hepatitis developing in the majority of patients. Although the natural history of recurrent HCV is difficult to predict, it is widely accepted that cirrhosis from recurrent HCV occurs in up to 30% of patients within five years of transplantation.

8 Jun 2011

Virus News and Research

Latest Virus News and Research

Humira defect lawyers file suit against Abbott Laboratories in federal court

Universal influenza vaccination may reduce health care costs in the U.S.

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

Scientists identify six influenza A viruses similar to 2009 pandemic strain

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

Cinryze data on hereditary angioedema presented at EAACI 2011

Viewpoints: Private vs. public Medicare; N.J. Medicaid tough choices; IPAB's cost controls

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

S. African government program reduced MTCT HIV transmission rate to 3.5%, study shows

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Swine flu may have been more widespread in Scotland than previously believed, study says

Quest Diagnostics receives MDEA gold award for Simplexa/3M technology

Global initiative to prevent HIV in babies

Ilex, Cerus partner to distribute INTERCEPT Blood System in Israel and South Africa

Adults with herpes zoster may face higher risk of multiple sclerosis

Adjuvant combination generates memory CD8 T cells which could kill infected cells

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in